EP2658871 - Bibliographic data

ANTICORPS ANTI-CD38

Last update 15/06/2025
Legal status Brevet délivré
Origin Euro-PCT
(73) Holder

Takeda Pharmaceutical Company Limited

1-1 Doshomachi 4-chome Chuo-ku
Osaka-shi, Osaka 541-0045
Japon
(72) Inventors

Kathleen Ann ELIAS

c/o Takeda California, Inc. 10410 Science Center Drive
San Diego, CA 92121
États-Unis d'Amérique

Gregory LANDES

c/o Takeda California, Inc. 10410 Science Center Drive
San Diego, CA 92121
États-Unis d'Amérique

Shweta SINGH

c/o Takeda California, Inc. 10410 Science Center Drive
San Diego, CA 92121
États-Unis d'Amérique

Wouter KORVER

c/o Takeda California, Inc. 10410 Science Center Drive
San Diego, CA 92121
États-Unis d'Amérique

Andrew Walling DRAKE

c/o Takeda California, Inc. 10410 Science Center Drive
San Diego, CA 92121
États-Unis d'Amérique

Mary HAAK-FRENDSCHO

c/o Takeda California, Inc. 10410 Science Center Drive
San Diego, CA 92121
États-Unis d'Amérique

Gyorgy Pal SNELL

c/o Takeda California, Inc. 10410 Science Center Drive
San Diego, CA 92121
États-Unis d'Amérique

Vinay BHASKAR

c/o Takeda California, Inc. 10410 Science Center Drive
San Diego, CA 92121
États-Unis d'Amérique
(74) Agent

Mail recipient

RWS GROUP

Europa House - Chiltern Park - Chiltern Hill
SL9 9FG
CHAFLONT ST PETER, Bucks
Royaume-Uni
(21) Request number EP11811633.4
(22) Request date 30/12/2011
(11) Publication number EP2658871
Publication date 02/05/2018
(54) Title of the invention ANTICORPS ANTI-CD38
(51) International classification C07K 16/28, A61P 35/02
International classification (before reform) None
Claimed priority

(31) Number: 201161470406 P
(32) Date: 31/03/2011
(33) Country: US

Initial application None
Divisional application EP17189925.5 /EP3284754 None
Expected annuity Annuity: 15 - Amount: 390 € - Due date 31/12/2025
Last annuity Annuity: 14 - Payment date 26/11/2024
Publication None
History

Publication de la délivrance du brevet européen - Legal date 02/05/2018

Constitution de mandataire pour un dossier - Legal date 10/08/2018